Abstract:Background The growth and metastasis of tumors depend on the development of an adequate blood supply via angiogenesis. Recent studies indicate that the inducible nitric oxide synthase (iNOS), vascular endothelial growth factor (VEGF) and the tumor suppressor p53 are fundamental play-markers of the angiogenic process. Overexpression of iNOS and VEGF has been shown to induce angiogenesis in tumors. P53 suppresses angiogenesis by down-regulating VEGF and iNOS. The correlation of expression of p53, VEGF and iNOS and clinical features in gastric carcinogenesis, however, has not been well characterized. Methods The expression of p53, iNOS and VEGF in gastric precancerous and cancerous lesions and its relation with the clinical features was determined with immunohistochemistry (avidin-biotin-peroxidase complex method) on 55 randomly selected GC patients and 60 symptom-free subjects from the mass survey in the high-incidence area for GC in Henan, northern China. Results The positive immunostainig rates for p53, iNOS and VEGF in gastric carcinomas were 51%, 44% and 51%, respectively, and correlated well with TNM stages, but did not show significant difference among the groups with different degrees of gastric wall invasion depth by GC. A positive immunostaining reaction for the iNOS protein was significantly correlated with lymph node metastasis (p = 0.019; Spearman correlation coefficient). P53 protein accumulation was higher in the poorly-differentiated gastric carcinoma than in well-differentiated one. In gastric biopsies, no positive immunosatining was observed for p53, iNOS and VEGF in the histologically normal tissue and chronic superficial gastritis (CSG). However, p53, iNOS and VEGF positive immunostaining was observed in the tissues with different severities of lesions of chronic atrophic gastritis (CAG), intestinal metaplasia (IM) and dysplasia (DYS), and the positive rates increased with the lesion progression from CAG to IM to DYS. A high coincidental positive and negative immunostaining rate for p53, iNOS and VEGF was observed both in biopsy samples with CAG, IM and DYS from the symptom-free subjects and in gastric cancer tissue from the GC patients. Conclusions The present results indicated that p53 protein accumulation and increased expression of iNOS and VEGF might be responsible for gastric carcinogenesis and tumor aggressiveness of gastric cancer.

Expressions of Serum VEGF and P53 in Patients with Gastric Carcinoma

The Potential for Serum P53 to Predict the Response to Chemotherapy of Patients with Gastric Cancer

The Expression and Clinical Significance of Vascular Endothelial Growth Factor-C in Gastric Cancer Tissues

Expression of Vascular Endothelial Growth Factor and its Prognostic Value in Gastric Cancer

Expression of Midkine and Vascular Endothelial Growth Factor and Their Significances in Gastric Carcinoma

Serum level of vascular endothelial growth factor in patients with gastric carcinoma and its clinical significance

Correlation of P53 and Vascular Endothelial Growth Factor Expression to Angiogen Esis in Gastric Carcinoma and Its Clinical Significance

Expression of P53, EGFR, HER-2, VEGF in Gastric Carcinoma and Its Relation with the Prognosis of Gastric Carcinoma Patients

Detection of Vascular Endothelial Growth Factor-A in Patients with Gastric Cancer and its Clinical Significance

The Clinical Significance of Serum VEGF Level in Gastric Cancer Patients

Relationship between expression of VEGF, Flt1, bFGF and P53 and outcome in patients with gastric carcinoma

The Change and Its Significance of Serum VEGF Bfgf in Gastric Carcinoma

Potential Prognostic Value of Circulating Levels of Vascular Endothelial Growth Factor-A in Patients with Gastric Cancer

The Levels of Plasma Vascular Endothelial Growth Factor and Tumor Necrosis Factor Α in Gastric Carcinoma and Their Significances

Expression of P16 and VEGF in Gastric Carcinoma and Its Clinical Significance

Expressions and clinical significance of Sirt1, P53 and P-gp in gastric carcinoma

Research on Mrna Expression and Clinical Significance of Peroxisome Proliferatm-activated Receptory and Vascular Endothelial Growth Factor C in Gastric Cancer Patients

Expression of hypoxia inducible factor-1α and vascular endothelial growth factor in gastric cancer tissues and its relationship with tumor cell proliferation

Expression of P21, P27, P53 and Rb Proteins and Their Clinical Significance in Gastric Carcinoma

Expression of P53, Inducible Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Gastric Precancerous and Cancerous Lesions: Correlation with Clinical Features

Relationship of vascular endothelial growth factor and p~(33ING1) with biological behaviors of gastric carcinoma